Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis.

Clere, Nicolas

Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. [electronic resource] - International journal of cancer Nov 2010 - 2279-91 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-0215

10.1002/ijc.25234 doi


Angiotensin II Type 2 Receptor Blockers
Animals
Carcinoma, Lewis Lung--blood supply
Cell Growth Processes--drug effects
Cell Transformation, Neoplastic--genetics
Female
Fibrosarcoma--blood supply
Gene Deletion
Imidazoles--pharmacology
Methylcholanthrene
Mice
Mice, Inbred C57BL
Mice, Knockout
Neovascularization, Pathologic--drug therapy
Pyridines--pharmacology
Receptor, Angiotensin, Type 2--deficiency
Reverse Transcriptase Polymerase Chain Reaction